中國天瑞水泥(01252.HK)年度純利18.6億元 同比增長2.3%
格隆匯3月22日丨中國天瑞水泥(01252.HK)發佈公吿,截至2020年12月31日止年度,公司收益121.7億元人民幣,同比增長0.7%;公司擁有人應占淨利潤18.6億元,同比增長2.3%;每股盈利0.63元。
截至2020年12月31日,集團共擁有熟料產能2840萬噸、水泥產能5640萬噸、骨料1920萬噸。2020年,集團水泥銷量約3580萬噸,同比增加約430萬噸,增幅為13.8%;平均價格約為每噸人民幣305.4元,較2019年每噸下降人民幣49.1元,降幅13.9%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.